Quest for the right Drug
איפו-סל 2 גרם IFO-CELL 2 G (IFOSFAMIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תמיסה לאינפוזיה : SOLUTION FOR INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The adverse reactions and frequencies below are based on publications describing clinical experience with fractionated administration of ifosfamide as monotherapy with a total dose of 4 to 12 g/m2 per course. ADR frequency is based upon the following scale: Very common (≥1/10); Common (≥1/100 - <1/10), Uncommon (≥1/1,000 - <1/100), Rare (≥1/10,000 - <1/1,000), Very rare (<1/10,000), Not known (adverse reactions reported in the post-marketing experience). System Organ Class Adverse Reaction Frequency Category (SOC) INFECTIONS AND Infections (including reactivation of latent Common INFESTATIONS infections) Not known Sepsis (septic shock)* NEOPLASMS BENIGN, Secondary tumors* (including Urinary tract Not known MALIGNANT AND carcinoma, Myelodysplastic syndrome, Acute UNSPECIFIED (INCL leukaemia, Acute lymphocytic leukaemia, CYCTS AND POLYPS) Lymphoma [Non-Hodgkin's lymphoma], Sarcomas, Renal cell carcinoma, Thyroid cancer) Not known Progressions of underlying malignancies* BLOOD AND LYMPHATIC Myelosuppression Very common SYSTEM DISORDERS - Leukopenia Very common - Thrombocytopenia* Very common - Anemia Not known - Agranulocytosis Not known Haematotoxicity* Not known - Hemolytic anemia Not known - Methaemoglobinaemia Not known Febrile bone marrow aplasia Not known Disseminated intravascular coagulation Not known Hemolytic uremic syndrome Not known Neonatal anemia Not known IMMUNE SYSTEM Angioedema* Not known DISORDERS Anaphylactic reaction Not known Immunosuppression Not known Urticaria Not known Hypersensitivity reaction Not known ENDOCRINE DISORDERS Syndrome of inappropriate antidiuretic Not known hormone secretion (SIADH) METABOLISM AND Decreased Appetite Common NUTRITION DISORDERS Tumor lysis syndrome Not known Metabolic acidosis Not known Hypokalaemia Not known Hypocalcaemia Not known Hypophosphataemia Not known Hyperglycemia Not known Polydipsia Not known PSYCHIATRIC Mutism Not known DISORDERS Mental status change (including mania, Not known paranoia, delusion, delirium, catatonia, amnesia, panic attack) Not known Echolalia Not known Perseveration NERVOUS SYSTEM Central nervous system toxicity Not known DISORDERS - Encephalopathy Not known - Faecal incontinence Not known - Status epilepticus* (convulsive and Not known nonconvulsive) Not known - Movement disorder Not known - Extrapyramidal disorder Not known - Gait disturbance Not known - Dysarthria Not known Peripheral neuropathy Not known - Hypoesthesia Not known - Paresthesia Not known Asterixis Not known Neuralgia Not known EYE DISORDERS Visual impairment Not known Conjunctivitis Not known Eye irritation Not known EAR AND LABYRINTH Deafness Not known DISORDERS Vertigo Not known Tinnitus Not known CARDIAC DISORDERS Cardiotoxicity* Uncommon Arrythmia (including supraventricular and Not known ventricular arrhythmia) Not known Atrial fibrillation Not known Premature atrial contractions Not known Bradycardia Not known Cardiac arrest* Not known Myocardial infarction Not known Cardiac failure* Not known Myocardial hemorrhage Not known Angina pectoris Not known Cardiomyopathy* (including congestive Not known cardiomyopathy) Not known Electrocardiogram ST-segment abnormal Not known Electrocardiogram T- wave inversion Not known Electrocardiogram QRS complex abnormal VASCULAR DISORDERS Hypotension Uncommon Pulmonary embolism Not known Deep vein thrombosis Not known Capillary leak syndrome Not known Vasculitis Not known Hypertension Not known Flushing Not known RESPIRATORY, Respiratory failure* Not known THORACIC, AND Acute respiratory distress syndrome* Not known MEDIASTINAL Pulmonary hypertension Not known DISORDERS Interstitial lung disease* (as manifested by Not known Pulmonary fibrosis) Not known Pneumonitis* Not known Pulmonary oedema* Not known Pleural effusion Not known Dyspnea Not known Hypoxia Not known Cough Not known GASTROINTESTINAL Nausea/Vomiting Very common DISORDERS Diarrhea Uncommon Stomatitis Uncommon Enterocolitis Not known Pancreatitis Not known Ileus Not known Gastrointestinal hemorrhage Not known Mucosal ulceration Not known Constipation Not known Abdominal pain Not known Salivary hypersecretion Not known HEPATOBILIARY Hepatotoxicity Common DISORDERS - Hepatic failure Not known Veno-occlusive liver disease Not known Portal vein thrombosis Not known Cytolytic hepatitis Not known SKIN AND Alopecia Very common SUBCUTANEOUS Dermatitis Rare TISSUE DISORDERS Papular rash Rare Toxic epidermal necrolysis Not known Stevens-Johnson syndrome Not known Palmar-plantar erythrodysesthesia syndrome Not known Radiation recall dermatitis Not known Skin necrosis Not known Facial swelling Not known Rash Not known Pruritus Not known Erythema Not known Skin hyperpigmentation Not known Hyperhidrosis Not known Nail disorder Not known MUSCULOSKELETAL Rhabdomyolysis Not known AND CONNECTIVE Osteomalacia Not known TISSUE DISORDERS Rickets Not known Growth retardation Not known Myalgia Not known Arthralgia Not known Muscle twitching Not known RENAL AND URINARY Haemorrhagic cystitis Very common DISORDERS Haematuria Very common Renal dysfunction* Very common - Acute renal failure Very common - Chronic renal failure Not known - Aminoaciduria Not known - Phosphaturia Not known - Fanconi syndrome Not known - Tubulointerstitial nephritis Not known Renal structural damage Not known Nephrogenic diabetes insipidus Not known Polyuria Not known Enuresis Not known Feeling of residual urine Not known REPRODUCTIVE Infertility Not known SYSTEM AND BREAST Ovarian failure Not known DISORDERS Premature menopause Not known Amenorrhea Not known Ovulation disorder Not known Azoospermia Not known Oligospermia Not known CONGENITAL, FAMILIAL Fetal growth retardation Not known AND GENETIC DISORDERS GENERAL DISORDERS Phlebitis Common AND ADMINISTRATIVE Fatigue Uncommon SITE CONDITIONS Malaise Not known Multiorgan failure* Not known General physical deterioration Not known Injection/Infusion site reactions Not known Oedema Not known Pain Not known Pyrexia Not known Chills Not known * including fatal outcomes Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף